Delynov Chirurgie, Delynov Mitral Repair: When the Resect vs Respect Duel Delivers its Verdict Mitral valve repair (MVr) is not merely about correcting a leak; its primary objective is to initiate left ventricular (LV) reverse remodelling, a physiological process... Jun 9, 2026
Delynov Chirurgie, Delynov Mitral Regurgitation: When M-TEER Boosts Systolic Flow in Atrial Forms Transcatheter edge-to-edge mitral repair (M-TEER) is an established therapeutic option for secondary mitral regurgitation (SMR). However, identifying pati... Jun 8, 2026
Delynov Chirurgie, Delynov Mitral and Tricuspid Regurgitation: When Double Repair is a Game-Changer Atrial dilated cardiomyopathy (AdCM) frequently leads to valvular annular dilation, causing severe secondary mitral regurgitation (MR) and tricuspid regurgitation (TR)... Jun 8, 2026
Delynov Chirurgie, Delynov Endocarditis and narrow root: when the Nicks technique prevents mismatch Surgical management of infectious endocarditis is further complicated when the patient's anatomy presents a narrow aortic root, increasing the risk of prosthesis-patient mismatch... Jun 8, 2026
Delynov Chirurgie, Delynov Tricuspid regurgitation: which animal model to simulate the functional form? Tricuspid regurgitation (TR) affects over 70 million people worldwide and has emerged as an independent predictor of mortality. While the functional form (FTR) dominates... Jun 8, 2026
Delynov Chirurgie, Delynov Endocarditis and IVFB: the hemi-UFO technique to preserve the mitral valve Managing extensive infective endocarditis on an aortic prosthesis, when it invades the intervalvular fibrous body (IVFB), represents one of the most challenging scenarios in cardiac surgery. Jun 5, 2026
Delynov Chirurgie, Delynov Thrombocytopenia and Antiphospholipids: When Minimally Invasive Surgery Changes the Game The coexistence of immune thrombocytopenic purpura (ITP) and antiphospholipid syndrome (APS) presents the cardiac surgeon with a major therapeutic paradox... Jun 4, 2026
Delynov Chirurgie, Delynov Stroke after mitral surgery: when age and new-onset AF change the game The expansion of mitral valve repair indications to increasingly elderly populations raises critical questions regarding long-term thromboembolic risk. While the... Jun 4, 2026
Delynov Chirurgie, Delynov Mitral valve repair: when stroke risk persists despite sinus rhythm The widespread adoption of mitral valve repair techniques has significantly shifted the profile of operated patients toward older age groups. While this evolution... Jun 4, 2026
Delynov Chirurgie, Delynov Obstructive HOCM: chordal cutting ensures long-term success of myectomy The advent of cardiac myosin inhibitors, such as mavacamten and aficamtene, is transforming the management of obstructive hypertrophic cardiomyopathy (HCM). Jun 1, 2026
Delynov Chirurgie, Delynov M-TEER: does long-term survival depend on the type of pulmonary hypertension? In patients over 75, mitral regurgitation (MR) is the most common valvular heart disease. For those whose surgical risk precludes conventional surgery... Jun 1, 2026
Delynov Chirurgie, Delynov Mitral Valve Repair: When Calibrated Autologous Pericardium Changes the Game Reconstruction of mitral leaflets in complex pathologies, particularly infectious endocarditis (representing 44% of this cohort), often requires the use of sub... May 29, 2026